Filing Details
- Accession Number:
- 0001562180-25-005065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-25 16:36:23
- Reporting Period:
- 2025-06-24
- Filing Date:
- 2025-06-25
- Accepted Time:
- 2025-06-25 16:36:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1460472 | Richard Giltner | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Transaction Summary
| Sold: | 3,036 shares | Avg. Price: $289.60 | Total Value: $879,214.06 |
| Number of Shares After Transactions: | 19,384 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-24 | 5,000 | $175.43 | 22,420 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-24 | 3,036 | $289.60 | 19,384 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-06-24 | 5,000 | $0.00 | 5,000 | $175.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-06-26 | 2025-06-26 | No | 4 | M | Direct |
Footnotes
- Exercise of stock options in a cashless sell-to-cover transaction, where a sufficient number of shares was sold to cover the exercise price.
Billionaire Hedge Funds
